ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Analgesic and Anti-inflammatory API Market Research Report 2026
Published Date: 2026-06-09
|
Report Code: QYRE-Auto-12E13557
Home | Market Reports | Health| Health Conditions| Pain Management
Global Analgesic and Anti inflammatory API Market Research Report 2023
BUY CHAPTERS

Global Analgesic and Anti-inflammatory API Market Research Report 2026

Code: QYRE-Auto-12E13557
Report
2026-06-09
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
IOL
Mallinckrodt Pharmaceuticals
Anqiu Lu’an Pharmaceutical
Novacyl
BASF AG
BBCA Group
Hubei Biocause Group
Xinhua Pharm
Granules India Limited
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hunan Zhongnan Pharmaceutical
Hebei Jingye Medical Technology

Analgesic and Anti-inflammatory API Market Size

The global Analgesic and Anti-inflammatory API market was valued at US$ 786 million in 2025 and is anticipated to reach US$ 1037 million by 2032, at a CAGR of 4.1% from 2026 to 2032.

Analgesic and Anti-inflammatory API Market

Analgesic and Anti-inflammatory API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Analgesic and Anti-inflammatory API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Analgesic and Anti-inflammatory API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Analgesic and Anti-inflammatory API. The Analgesic and Anti-inflammatory API market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Analgesic and Anti-inflammatory API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Analgesic and Anti-inflammatory API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Analgesic and Anti-inflammatory API Market Report

Report Metric Details
Report Name Analgesic and Anti-inflammatory API Market
Accounted market size in 2025 US$ 786 million
Forecasted market size in 2032 US$ 1037 million
CAGR 4.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Ibuprofen
  • Paracetamol
  • Aspirin
  • Naproxen
  • Diclofenac
  • Oxaprozin
  • Dexibuprofen
  • Others
by Application
  • Adults
  • Children
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, BBCA Group, Hubei Biocause Group, Xinhua Pharm, Granules India Limited, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hunan Zhongnan Pharmaceutical, Hebei Jingye Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Analgesic and Anti-inflammatory API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Analgesic and Anti-inflammatory API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Analgesic and Anti-inflammatory API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Analgesic and Anti-inflammatory API Market growing?

Ans: The Analgesic and Anti-inflammatory API Market witnessing a CAGR of 4.1% during the forecast period 2026-2032.

What is the Analgesic and Anti-inflammatory API Market size in 2032?

Ans: The Analgesic and Anti-inflammatory API Market size in 2032 will be US$ 1037 million.

Who are the main players in the Analgesic and Anti-inflammatory API Market report?

Ans: The main players in the Analgesic and Anti-inflammatory API Market are IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, BBCA Group, Hubei Biocause Group, Xinhua Pharm, Granules India Limited, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hunan Zhongnan Pharmaceutical, Hebei Jingye Medical Technology

What are the Application segmentation covered in the Analgesic and Anti-inflammatory API Market report?

Ans: The Applications covered in the Analgesic and Anti-inflammatory API Market report are Adults, Children

What are the Type segmentation covered in the Analgesic and Anti-inflammatory API Market report?

Ans: The Types covered in the Analgesic and Anti-inflammatory API Market report are Ibuprofen, Paracetamol, Aspirin, Naproxen, Diclofenac, Oxaprozin, Dexibuprofen, Others

1 Analgesic and Anti-inflammatory API Market Overview
1.1 Product Definition
1.2 Analgesic and Anti-inflammatory API by Type
1.2.1 Global Analgesic and Anti-inflammatory API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Ibuprofen
1.2.3 Paracetamol
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
1.3 Analgesic and Anti-inflammatory API by Application
1.3.1 Global Analgesic and Anti-inflammatory API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Adults
1.3.3 Children
1.4 Global Market Growth Prospects
1.4.1 Global Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Analgesic and Anti-inflammatory API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Analgesic and Anti-inflammatory API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Analgesic and Anti-inflammatory API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Analgesic and Anti-inflammatory API Production Market Share by Manufacturers (2021–2026)
2.2 Global Analgesic and Anti-inflammatory API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Analgesic and Anti-inflammatory API, Industry Ranking, 2024 vs 2025
2.4 Global Analgesic and Anti-inflammatory API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Analgesic and Anti-inflammatory API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Analgesic and Anti-inflammatory API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Analgesic and Anti-inflammatory API, Product Offerings and Applications
2.8 Global Key Manufacturers of Analgesic and Anti-inflammatory API, Date of Entry into the Industry
2.9 Analgesic and Anti-inflammatory API Market Competitive Situation and Trends
2.9.1 Analgesic and Anti-inflammatory API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Analgesic and Anti-inflammatory API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Analgesic and Anti-inflammatory API Production by Region
3.1 Global Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Analgesic and Anti-inflammatory API Production Value by Region (2021–2032)
3.2.1 Global Analgesic and Anti-inflammatory API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Analgesic and Anti-inflammatory API by Region (2027–2032)
3.3 Global Analgesic and Anti-inflammatory API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Analgesic and Anti-inflammatory API Production Volume by Region (2021–2032)
3.4.1 Global Analgesic and Anti-inflammatory API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Analgesic and Anti-inflammatory API by Region (2027–2032)
3.5 Global Analgesic and Anti-inflammatory API Market Price Analysis by Region (2021–2026)
3.6 Global Analgesic and Anti-inflammatory API Production, Value, and Year-over-Year Growth
3.6.1 North America Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021–2032)
4 Analgesic and Anti-inflammatory API Consumption by Region
4.1 Global Analgesic and Anti-inflammatory API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Analgesic and Anti-inflammatory API Consumption by Region (2021–2032)
4.2.1 Global Analgesic and Anti-inflammatory API Consumption by Region (2021–2026)
4.2.2 Global Analgesic and Anti-inflammatory API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Analgesic and Anti-inflammatory API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Analgesic and Anti-inflammatory API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Analgesic and Anti-inflammatory API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Analgesic and Anti-inflammatory API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Analgesic and Anti-inflammatory API Production by Type (2021–2032)
5.1.1 Global Analgesic and Anti-inflammatory API Production by Type (2021–2026)
5.1.2 Global Analgesic and Anti-inflammatory API Production by Type (2027–2032)
5.1.3 Global Analgesic and Anti-inflammatory API Production Market Share by Type (2021–2032)
5.2 Global Analgesic and Anti-inflammatory API Production Value by Type (2021–2032)
5.2.1 Global Analgesic and Anti-inflammatory API Production Value by Type (2021–2026)
5.2.2 Global Analgesic and Anti-inflammatory API Production Value by Type (2027–2032)
5.2.3 Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2021–2032)
5.3 Global Analgesic and Anti-inflammatory API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Analgesic and Anti-inflammatory API Production by Application (2021–2032)
6.1.1 Global Analgesic and Anti-inflammatory API Production by Application (2021–2026)
6.1.2 Global Analgesic and Anti-inflammatory API Production by Application (2027–2032)
6.1.3 Global Analgesic and Anti-inflammatory API Production Market Share by Application (2021–2032)
6.2 Global Analgesic and Anti-inflammatory API Production Value by Application (2021–2032)
6.2.1 Global Analgesic and Anti-inflammatory API Production Value by Application (2021–2026)
6.2.2 Global Analgesic and Anti-inflammatory API Production Value by Application (2027–2032)
6.2.3 Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2021–2032)
6.3 Global Analgesic and Anti-inflammatory API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 IOL
7.1.1 IOL Analgesic and Anti-inflammatory API Company Information
7.1.2 IOL Analgesic and Anti-inflammatory API Product Portfolio
7.1.3 IOL Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 IOL Main Business and Markets Served
7.1.5 IOL Recent Developments/Updates
7.2 Mallinckrodt Pharmaceuticals
7.2.1 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Company Information
7.2.2 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolio
7.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.3 Anqiu Lu'an Pharmaceutical
7.3.1 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Company Information
7.3.2 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
7.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Anqiu Lu'an Pharmaceutical Main Business and Markets Served
7.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
7.4 Novacyl
7.4.1 Novacyl Analgesic and Anti-inflammatory API Company Information
7.4.2 Novacyl Analgesic and Anti-inflammatory API Product Portfolio
7.4.3 Novacyl Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Novacyl Main Business and Markets Served
7.4.5 Novacyl Recent Developments/Updates
7.5 BASF
7.5.1 BASF Analgesic and Anti-inflammatory API Company Information
7.5.2 BASF Analgesic and Anti-inflammatory API Product Portfolio
7.5.3 BASF Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 BASF Main Business and Markets Served
7.5.5 BASF Recent Developments/Updates
7.6 BBCA Group
7.6.1 BBCA Group Analgesic and Anti-inflammatory API Company Information
7.6.2 BBCA Group Analgesic and Anti-inflammatory API Product Portfolio
7.6.3 BBCA Group Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 BBCA Group Main Business and Markets Served
7.6.5 BBCA Group Recent Developments/Updates
7.7 Hubei Biocause Group
7.7.1 Hubei Biocause Group Analgesic and Anti-inflammatory API Company Information
7.7.2 Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolio
7.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Hubei Biocause Group Main Business and Markets Served
7.7.5 Hubei Biocause Group Recent Developments/Updates
7.8 Xinhua Pharm
7.8.1 Xinhua Pharm Analgesic and Anti-inflammatory API Company Information
7.8.2 Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolio
7.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Xinhua Pharm Main Business and Markets Served
7.8.5 Xinhua Pharm Recent Developments/Updates
7.9 Granules India Limited
7.9.1 Granules India Limited Analgesic and Anti-inflammatory API Company Information
7.9.2 Granules India Limited Analgesic and Anti-inflammatory API Product Portfolio
7.9.3 Granules India Limited Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Granules India Limited Main Business and Markets Served
7.9.5 Granules India Limited Recent Developments/Updates
7.10 Hebei Jiheng Pharmaceutical
7.10.1 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Company Information
7.10.2 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
7.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Hebei Jiheng Pharmaceutical Main Business and Markets Served
7.10.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
7.11 Zhejiang Kangle Pharmaceutical
7.11.1 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Company Information
7.11.2 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
7.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Zhejiang Kangle Pharmaceutical Main Business and Markets Served
7.11.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
7.12 Hunan Zhongnan Pharmaceutical
7.12.1 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Company Information
7.12.2 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
7.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Hunan Zhongnan Pharmaceutical Main Business and Markets Served
7.12.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
7.13 Hebei Jingye Medical Technology
7.13.1 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Company Information
7.13.2 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolio
7.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Hebei Jingye Medical Technology Main Business and Markets Served
7.13.5 Hebei Jingye Medical Technology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Analgesic and Anti-inflammatory API Industry Chain Analysis
8.2 Analgesic and Anti-inflammatory API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Analgesic and Anti-inflammatory API Production Modes and Processes
8.4 Analgesic and Anti-inflammatory API Sales and Marketing
8.4.1 Analgesic and Anti-inflammatory API Sales Channels
8.4.2 Analgesic and Anti-inflammatory API Distributors
8.5 Analgesic and Anti-inflammatory API Customer Analysis
9 Analgesic and Anti-inflammatory API Market Dynamics
9.1 Analgesic and Anti-inflammatory API Industry Trends
9.2 Analgesic and Anti-inflammatory API Market Drivers
9.3 Analgesic and Anti-inflammatory API Market Challenges
9.4 Analgesic and Anti-inflammatory API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
IOL
Mallinckrodt Pharmaceuticals
Anqiu Lu’an Pharmaceutical
Novacyl
BASF AG
BBCA Group
Hubei Biocause Group
Xinhua Pharm
Granules India Limited
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hunan Zhongnan Pharmaceutical
Hebei Jingye Medical Technology
List of Tables
 Table 1. Global Analgesic and Anti-inflammatory API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Analgesic and Anti-inflammatory API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Analgesic and Anti-inflammatory API Production Capacity (Tons) by Manufacturers in 2025
 Table 4. Global Analgesic and Anti-inflammatory API Production by Manufacturers (Tons), 2021–2026
 Table 5. Global Analgesic and Anti-inflammatory API Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Analgesic and Anti-inflammatory API Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Analgesic and Anti-inflammatory API Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Analgesic and Anti-inflammatory API, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Analgesic and Anti-inflammatory API Production Value, 2025
 Table 10. Global Market Analgesic and Anti-inflammatory API Average Price by Manufacturers (US$/Ton), 2021–2026
 Table 11. Global Key Manufacturers of Analgesic and Anti-inflammatory API, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Analgesic and Anti-inflammatory API, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Analgesic and Anti-inflammatory API, Date of Entry into the Industry
 Table 14. Global Analgesic and Anti-inflammatory API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Analgesic and Anti-inflammatory API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Analgesic and Anti-inflammatory API Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Analgesic and Anti-inflammatory API Production Value Market Share by Region (2021–2026)
 Table 19. Global Analgesic and Anti-inflammatory API Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Analgesic and Anti-inflammatory API Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Analgesic and Anti-inflammatory API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Analgesic and Anti-inflammatory API Production (Tons) by Region (2021–2026)
 Table 23. Global Analgesic and Anti-inflammatory API Production Market Share by Region (2021–2026)
 Table 24. Global Analgesic and Anti-inflammatory API Production (Tons) Forecast by Region (2027–2032)
 Table 25. Global Analgesic and Anti-inflammatory API Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Analgesic and Anti-inflammatory API Market Average Price (US$/Ton) by Region (2021–2026)
 Table 27. Global Analgesic and Anti-inflammatory API Market Average Price (US$/Ton) by Region (2027–2032)
 Table 28. Global Analgesic and Anti-inflammatory API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 29. Global Analgesic and Anti-inflammatory API Consumption by Region (Tons), 2021–2026
 Table 30. Global Analgesic and Anti-inflammatory API Consumption Market Share by Region (2021–2026)
 Table 31. Global Analgesic and Anti-inflammatory API Forecasted Consumption by Region (Tons), 2027–2032
 Table 32. Global Analgesic and Anti-inflammatory API Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 34. North America Analgesic and Anti-inflammatory API Consumption by Country (Tons), 2021–2026
 Table 35. North America Analgesic and Anti-inflammatory API Consumption by Country (Tons), 2027–2032
 Table 36. Europe Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 37. Europe Analgesic and Anti-inflammatory API Consumption by Country (Tons), 2021–2026
 Table 38. Europe Analgesic and Anti-inflammatory API Consumption by Country (Tons), 2027–2032
 Table 39. Asia Pacific Analgesic and Anti-inflammatory API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 40. Asia Pacific Analgesic and Anti-inflammatory API Consumption by Region (Tons), 2021–2026
 Table 41. Asia Pacific Analgesic and Anti-inflammatory API Consumption by Region (Tons), 2027–2032
 Table 42. Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 43. Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (Tons), 2021–2026
 Table 44. Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (Tons), 2027–2032
 Table 45. Global Analgesic and Anti-inflammatory API Production (Tons) by Type (2021–2026)
 Table 46. Global Analgesic and Anti-inflammatory API Production (Tons) by Type (2027–2032)
 Table 47. Global Analgesic and Anti-inflammatory API Production Market Share by Type (2021–2026)
 Table 48. Global Analgesic and Anti-inflammatory API Production Market Share by Type (2027–2032)
 Table 49. Global Analgesic and Anti-inflammatory API Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Analgesic and Anti-inflammatory API Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2021–2026)
 Table 52. Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2027–2032)
 Table 53. Global Analgesic and Anti-inflammatory API Price (US$/Ton) by Type (2021–2026)
 Table 54. Global Analgesic and Anti-inflammatory API Price (US$/Ton) by Type (2027–2032)
 Table 55. Global Analgesic and Anti-inflammatory API Production (Tons) by Application (2021–2026)
 Table 56. Global Analgesic and Anti-inflammatory API Production (Tons) by Application (2027–2032)
 Table 57. Global Analgesic and Anti-inflammatory API Production Market Share by Application (2021–2026)
 Table 58. Global Analgesic and Anti-inflammatory API Production Market Share by Application (2027–2032)
 Table 59. Global Analgesic and Anti-inflammatory API Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Analgesic and Anti-inflammatory API Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2021–2026)
 Table 62. Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2027–2032)
 Table 63. Global Analgesic and Anti-inflammatory API Price (US$/Ton) by Application (2021–2026)
 Table 64. Global Analgesic and Anti-inflammatory API Price (US$/Ton) by Application (2027–2032)
 Table 65. IOL Analgesic and Anti-inflammatory API Company Information
 Table 66. IOL Analgesic and Anti-inflammatory API Specification and Application
 Table 67. IOL Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 68. IOL Main Business and Markets Served
 Table 69. IOL Recent Developments/Updates
 Table 70. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Company Information
 Table 71. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Specification and Application
 Table 72. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 73. Mallinckrodt Pharmaceuticals Main Business and Markets Served
 Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 75. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Company Information
 Table 76. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Specification and Application
 Table 77. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 78. Anqiu Lu'an Pharmaceutical Main Business and Markets Served
 Table 79. Anqiu Lu'an Pharmaceutical Recent Developments/Updates
 Table 80. Novacyl Analgesic and Anti-inflammatory API Company Information
 Table 81. Novacyl Analgesic and Anti-inflammatory API Specification and Application
 Table 82. Novacyl Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 83. Novacyl Main Business and Markets Served
 Table 84. Novacyl Recent Developments/Updates
 Table 85. BASF Analgesic and Anti-inflammatory API Company Information
 Table 86. BASF Analgesic and Anti-inflammatory API Specification and Application
 Table 87. BASF Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 88. BASF Main Business and Markets Served
 Table 89. BASF Recent Developments/Updates
 Table 90. BBCA Group Analgesic and Anti-inflammatory API Company Information
 Table 91. BBCA Group Analgesic and Anti-inflammatory API Specification and Application
 Table 92. BBCA Group Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 93. BBCA Group Main Business and Markets Served
 Table 94. BBCA Group Recent Developments/Updates
 Table 95. Hubei Biocause Group Analgesic and Anti-inflammatory API Company Information
 Table 96. Hubei Biocause Group Analgesic and Anti-inflammatory API Specification and Application
 Table 97. Hubei Biocause Group Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 98. Hubei Biocause Group Main Business and Markets Served
 Table 99. Hubei Biocause Group Recent Developments/Updates
 Table 100. Xinhua Pharm Analgesic and Anti-inflammatory API Company Information
 Table 101. Xinhua Pharm Analgesic and Anti-inflammatory API Specification and Application
 Table 102. Xinhua Pharm Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 103. Xinhua Pharm Main Business and Markets Served
 Table 104. Xinhua Pharm Recent Developments/Updates
 Table 105. Granules India Limited Analgesic and Anti-inflammatory API Company Information
 Table 106. Granules India Limited Analgesic and Anti-inflammatory API Specification and Application
 Table 107. Granules India Limited Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 108. Granules India Limited Main Business and Markets Served
 Table 109. Granules India Limited Recent Developments/Updates
 Table 110. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Company Information
 Table 111. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Specification and Application
 Table 112. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 113. Hebei Jiheng Pharmaceutical Main Business and Markets Served
 Table 114. Hebei Jiheng Pharmaceutical Recent Developments/Updates
 Table 115. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Company Information
 Table 116. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Specification and Application
 Table 117. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 118. Zhejiang Kangle Pharmaceutical Main Business and Markets Served
 Table 119. Zhejiang Kangle Pharmaceutical Recent Developments/Updates
 Table 120. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Company Information
 Table 121. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Specification and Application
 Table 122. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 123. Hunan Zhongnan Pharmaceutical Main Business and Markets Served
 Table 124. Hunan Zhongnan Pharmaceutical Recent Developments/Updates
 Table 125. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Company Information
 Table 126. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Specification and Application
 Table 127. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 128. Hebei Jingye Medical Technology Main Business and Markets Served
 Table 129. Hebei Jingye Medical Technology Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Analgesic and Anti-inflammatory API Distributors List
 Table 133. Analgesic and Anti-inflammatory API Customers List
 Table 134. Analgesic and Anti-inflammatory API Market Trends
 Table 135. Analgesic and Anti-inflammatory API Market Drivers
 Table 136. Analgesic and Anti-inflammatory API Market Challenges
 Table 137. Analgesic and Anti-inflammatory API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Analgesic and Anti-inflammatory API
 Figure 2. Global Analgesic and Anti-inflammatory API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Analgesic and Anti-inflammatory API Market Share by Type: 2025 vs 2032
 Figure 4. Ibuprofen Product Picture
 Figure 5. Paracetamol Product Picture
 Figure 6. Aspirin Product Picture
 Figure 7. Naproxen Product Picture
 Figure 8. Diclofenac Product Picture
 Figure 9. Oxaprozin Product Picture
 Figure 10. Dexibuprofen Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Analgesic and Anti-inflammatory API Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Analgesic and Anti-inflammatory API Market Share by Application: 2025 vs 2032
 Figure 14. Adults
 Figure 15. Children
 Figure 16. Global Analgesic and Anti-inflammatory API Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Analgesic and Anti-inflammatory API Production Value (US$ Million), 2021–2032
 Figure 18. Global Analgesic and Anti-inflammatory API Production Capacity (Tons), 2021–2032
 Figure 19. Global Analgesic and Anti-inflammatory API Production (Tons), 2021–2032
 Figure 20. Global Analgesic and Anti-inflammatory API Average Price (US$/Ton), 2021–2032
 Figure 21. Analgesic and Anti-inflammatory API Report Years Considered
 Figure 22. Analgesic and Anti-inflammatory API Production Share by Manufacturers in 2025
 Figure 23. Global Analgesic and Anti-inflammatory API Production Value Share by Manufacturers (2025)
 Figure 24. Analgesic and Anti-inflammatory API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Top 5 and Top 10 Global Players: Market Share by Analgesic and Anti-inflammatory API Revenue in 2025
 Figure 26. Global Analgesic and Anti-inflammatory API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 27. Global Analgesic and Anti-inflammatory API Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 28. Global Analgesic and Anti-inflammatory API Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 29. Global Analgesic and Anti-inflammatory API Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 30. North America Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 31. Europe Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 32. China Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 33. Japan Analgesic and Anti-inflammatory API Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 34. Global Analgesic and Anti-inflammatory API Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 35. Global Analgesic and Anti-inflammatory API Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 36. North America Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 37. North America Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021–2032)
 Figure 38. U.S. Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. Canada Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 40. Europe Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Europe Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021–2032)
 Figure 42. Germany Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 43. France Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 44. U.K. Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 45. Italy Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. Russia Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. Asia Pacific Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. Asia Pacific Analgesic and Anti-inflammatory API Consumption Market Share by Region (2021–2032)
 Figure 49. China Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. Japan Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 51. South Korea Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 52. China Taiwan Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 53. Southeast Asia Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. India Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 56. Latin America, Middle East & Africa Analgesic and Anti-inflammatory API Consumption Market Share by Country (2021–2032)
 Figure 57. Mexico Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 58. Brazil Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 59. Turkey Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 60. GCC Countries Analgesic and Anti-inflammatory API Consumption and Growth Rate (Tons), 2021–2032
 Figure 61. Global Production Market Share of Analgesic and Anti-inflammatory API by Type (2021–2032)
 Figure 62. Global Production Value Market Share of Analgesic and Anti-inflammatory API by Type (2021–2032)
 Figure 63. Global Analgesic and Anti-inflammatory API Price (US$/Ton) by Type (2021–2032)
 Figure 64. Global Production Market Share of Analgesic and Anti-inflammatory API by Application (2021–2032)
 Figure 65. Global Production Value Market Share of Analgesic and Anti-inflammatory API by Application (2021–2032)
 Figure 66. Global Analgesic and Anti-inflammatory API Price (US$/Ton) by Application (2021–2032)
 Figure 67. Analgesic and Anti-inflammatory API Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Painkiller Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
OTC Painkiller Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NSAID API Market Research Report 2024
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Narcotic Analgesics Market Research Report 2025
Pharma Grade Ibuprofen API Market
Human Pain Management Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Care Products Market Research Report 2024
Global Anti inflammatory Agents Market Research Report 2024
Chronic Pain Topical Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antipyretic Analgesics Market Insights Forecast to 2030
Global Analgesic Creams Market Insights Forecast to 2030
Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024
Codeine Painkillers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dental NSAIDs Market Research Report 2025
Global Anti inflammatory Drugs for Dental Market Research Report 2024
Global Osteoarthritis Pain Drugs Market Insights Forecast to 2030
Cox 2 Inhibitors Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions